C5AR1 and hepatocellular carcinoma: In the current study, we demonstrated that LukS-PV targeting C5aR1 inhibited HCC cell proliferation by downregulating HDAC7 to upregulate the acetylation level of β-catenin, thus promoting the degradation of β-catenin through the ubiquitin–proteasome system.